Posted by Clinical Lab Products | Jun 10, 2005 | Cancer, Miscellaneous |
Nanogen and Pathway Diagnostics Sign License Agreement In an effort to develop optimal drug regimens and dosing strategies for therapeutic options used by patients suffering from psychiatric diseases, Nanogen Inc and Pathway Diagnostics have ente
Read MorePosted by Clinical Lab Products | Aug 11, 2004 | Cancer, Miscellaneous |
Atlas Medical Software to Help Sponsor 2004 Lab Institute Atlas Medical Software will be a platinum sponsor of the G-2 Reports’ 2004 Lab Institute, September 29–October 2 in Arlington, Va. The mission of the G-2 conference is to guide
Read MorePosted by Clinical Lab Products | Jul 12, 2004 | Cancer, Miscellaneous, Osteoporosis |
Roche and Premier Continue Partnership Roche Diagnostics Corp and Premier Purchasing Partners LLP have signed a 3-year agreement in which Roche will continue to provide instruments, reagents, and consumables to Premier members. The contract includ
Read MorePosted by Clinical Lab Products | Jun 6, 2004 | Cancer, Miscellaneous |
You might want to think twice before eating that second Twinkie. More and more studies are documenting the relationship between excessive weight and cancer. Recent reports suggest that obesity is linked to as many as 12 types of cancer, and in adu
Read MorePosted by Clinical Lab Products | May 31, 2004 | Cancer, Molecular Diagnostics |
Interview with Hank Nordhoff, Chairman, President, and CEO Hank Nordhoff Gen-Probe is a global leader in the development, manufacture, and marketing of rapid, accurate, and cost-effective nucleic acid testing products used to diagnose human dise
Read More